{
    "2020-11-19": [
        [
            {
                "time": "2021-11-19",
                "original_text": "Baricitinib Receives Emergency Use Authorization from the FDA for the Treatment of Hospitalized Patients with COVID-19",
                "features": {
                    "keywords": [
                        "Baricitinib",
                        "Emergency Use Authorization",
                        "FDA",
                        "COVID-19"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2021-11-19",
                "original_text": "What Awaits Pharma Giants in Last Lap of COVID-19 Vaccine Race?",
                "features": {
                    "keywords": [
                        "Pharma Giants",
                        "COVID-19 Vaccine Race"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-11-19",
                "original_text": "Lilly and Ypsomed collaborate to advance an automated insulin delivery system for people with diabetes",
                "features": {
                    "keywords": [
                        "Lilly",
                        "Ypsomed",
                        "automated insulin delivery",
                        "diabetes"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "medical devices"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            }
        ]
    ]
}